Unchained Labs is a life sciences company that focuses on getting researchers the right tools for the job. In February, the company announced that it had launched Stuntman. The next-generation automation platform combines native, natural-language AI with fully flexible hardware to fundamentally change how scientists interact with automation. Stuntman lets teams get answers faster and iterate with less friction, using a platform that adapts to their science and speaks their language–not the other way around.

For too many researchers, automation still feels harder than it should. Systems are built around rigid scripts and fixed workflows that force teams to translate ideas into code, manage complex setups, and rely on specialized expertise just to make progress. Iterating on an experiment can mean rewriting methods, reconfiguring hardware, or starting over entirely–turning automation into something that slows science down instead of speeding it up.

Stuntman customizes automation. With a large-language-model-driven AI embedded directly into the platform, scientists can describe what they want to do in plain language and turn those prompts into executable workflows, or dive deeper with programmatic control if needed. The AI helps plan experiments, guide closed-loop automation, and interpret results, while every condition, step, and data point is captured in open, structured formats. Its fully modular deck lets teams build the system they actually want–not a one-size-fits-all setup–from day one. “Automation should meet researchers where they work,” according to Tim Harkness, Founder and CEO at Unchained Labs. “Stuntman reduces complexity, speeds iteration, and lets teams stay focused on their science instead of wrangling their system. It offers the simplicity they want with the power they need–all while keeping AI in the loop.”

Earlier in the year, the company released a new application for Stunner, the only plate-based dynamic light scattering and Ultraviolet-Visible (UV/Vis) tool built for biologics. The new application delivers rapid, low-volume antibody-drug conjugate (ADC) characterization on up to 96 samples at a time.

ADCs are complicated, and pinning down exactly what you have made is tough–especially early in development when sample details are scarce and the process is still in flux. Simple UV/Vis methods fail to resolve overlapping signals without perfect inputs, while heavy-duty analytical tools may not be needed for quick screens, burning through samples and reducing throughput with tedious method development.

Stunner’s ADC Decode simplifies ADC screening, unlocking fast, reliable answers on drug-antibody ratio (DAR), concentration, and size–even when the sample information is limited. It cleanly separates antibody and drug contributions, untangling the overlapping signals that confuse standard UV/Vis methods while eliminating the long wait times of serial, one-by-one measurements. By teaming up UV/Vis and dynamic light scattering, Stunner helps researchers race through conjugation comparisons, check consistency across process steps, and make better decisions earlier in development.

“ADCs are exploding, and researchers need a fast way to screen conjugates before investing in deeper characterization,” according to Krystin Schmidt, VP Marketing at Unchained Labs. “Stunner’s new ADC Decode application serves up the simplest, most walk-up way to get DAR and concentration analysis.”

For more information about Unchained Labs, please visit www.unchainedlabs.com, www.linkedin.com/company/unchained-labs, or www.youtube.com/c/UnchainedLabs. For more information about Stuntman, please visit www.unchainedlabs.com/stuntman. For more information about Stunner, please visit www.unchainedlabs.com/stunner.